A carregar...

Thalidomide and lenalidomide for recurrent ovarian cancer: A systematic review of the literature

The present review aimed to assess the safety and efficacy of thalidomide and lenalidomide, two immunomodulatory drugs with anti-angiogenic properties, in women with recurrent ovarian, fallopian tube, and primary peritoneal cancer. A systematic review of the literature was conducted whereby Medline...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Tempfer, Clemens B., Schultheis, Beate, Hilal, Ziad, Dogan, Askin, Rezniczek, Günther A.
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5587990/
https://ncbi.nlm.nih.gov/pubmed/28927084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6578
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!